Literature DB >> 26836181

Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.

Tomoyuki Nagata1, Shunichiro Shinagawa1, Shinichiro Nakajima2,3,4,5, Eric Plitman3,6, Yukiko Mihashi3, Shogo Hayashi7, Masaru Mimura2, Kazuhiko Nakayama1.   

Abstract

BACKGROUND: The Neuropsychiatric Inventory (NPI) comprises 12 items, which were conventionally determined by psychopathological symptoms of patients with dementia. The clinical rating scales with structured questionnaires have been useful to evaluate neuropsychiatric symptoms (NPSs) of patients with dementia over the past twenty year.
OBJECTIVE: The aim of this study was to classify the conventional NPSs in patients with Alzheimer's disease (AD) requiring antipsychotic treatment for their NPSs into distinct clusters to simplify assessment of these numerous symptoms.
METHODS: Twelve items scores (product of severity and frequency of each symptom) in the NPI taken from the baseline visit were classified into subgroups by principle component analysis using data from 421 outpatients with AD enrolled in the Clinical Antipsychotic Trials of Intervention Effectiveness-Alzheimer's Disease (CATIE-AD) Phase 1. Chi square tests were conducted to examine the co-occurrence of the subgroups.
RESULTS: We found four distinct clusters: aggressiveness (agitation and irritabilities), apathy and eating problems (apathy and appetite/eating disturbance), psychosis (delusions and hallucinations), and emotion and disinhibition (depression, euphoria, and disinhibition). Anxiety, aberrant motor behavior, and sleep disturbance were not included by these clusters. Apathy and eating problems, and emotion and disinhibition co-occurred (p = 0.002), whereas aggressiveness and psychosis occurred independent of the other clusters.
CONCLUSIONS: Four distinct category clusters were identified from NPSs in patients with AD requiring antipsychotic treatment. Future studies should investigate psychosocial backgrounds or risk factors of each distinct cluster, in addition to their longitudinal course over treatment intervention.

Entities:  

Keywords:  Alzheimer’s disease; delusions; neuropsychiatric symptoms; principal component analysis

Mesh:

Substances:

Year:  2016        PMID: 26836181     DOI: 10.3233/JAD-150869

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

Review 1.  Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-15       Impact factor: 5.081

Review 2.  Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.

Authors:  Viktoria Mühlbauer; Ralph Möhler; Martin N Dichter; Sytse U Zuidema; Sascha Köpke; Hendrika J Luijendijk
Journal:  Cochrane Database Syst Rev       Date:  2021-12-17

Review 3.  Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review.

Authors:  Jiří Masopust; Dita Protopopová; Martin Vališ; Zbyšek Pavelek; Blanka Klímová
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-09       Impact factor: 2.570

4.  Blocking beta 2-adrenergic receptor inhibits dendrite ramification in a mouse model of Alzheimer's disease.

Authors:  Qin Wu; Jin-Xia Sun; Xiang-He Song; Jing Wang; Cun-Quan Xiong; Fei-Xiang Teng; Cui-Xiang Gao
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

5.  Predictors of nursing home placement at 2 years in Alzheimer's disease: A follow-up survey from the THERAD study.

Authors:  Hélène Villars; Virginie Gardette; Pauline Frayssignes; Eva Deperetti; Amélie Perrin; Christelle Cantet; Maria Soto-Martin
Journal:  Int J Geriatr Psychiatry       Date:  2022-04-30       Impact factor: 3.850

Review 6.  Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta-analysis.

Authors:  Shaun Kuan Wei Hiu; Theophile Bigirumurame; Patience Kunonga; Andrew Bryant; Manjunadh Pillai
Journal:  Brain Behav       Date:  2022-08-08       Impact factor: 3.405

7.  A Possibility of Simultaneous Treatment with the Multicomponent Drug, Ninjin'yoeito, for Anorexia, Apathy, and Cognitive Dysfunction in Frail Alzheimer's Disease Patients: An Open-Label Pilot Study.

Authors:  Makoto Ohsawa; Yukiko Tanaka; Yoshito Ehara; Setsuko Makita; Kosuke Onaka
Journal:  J Alzheimers Dis Rep       Date:  2017-12-09

Review 8.  Appetite, Metabolism and Hormonal Regulation in Normal Ageing and Dementia.

Authors:  Artemissia-Phoebe Nifli
Journal:  Diseases       Date:  2018-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.